MedPath
FDA Approval

Tobramycin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 27, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tobramycin(300 mg in 4 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tobramycin

Product Details

NDC Product Code
0093-3750
Application Number
ANDA210915
Marketing Category
ANDA (C73584)
Route of Administration
RESPIRATORY (INHALATION)
Effective Date
October 27, 2023
Code: VZ8RRZ51VKClass: ACTIBQuantity: 300 mg in 4 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCFClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath